News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘ProstateCancer’ clear

  • Researchers from the Broad Institute, Dana-Farber Cancer Institute and Weill Cornell Medical College have laid bare the full genetic blueprint of multiple prostate tumors, uncovering alterations that have never before been detected and offering a deep view of the genetic missteps that underlie the disease.

Tags: Genomics, ProstateCancer

  • New research from the Dana-Farber/Brigham and Women's Cancer Center shows that newer, more expensive treatment options for prostate cancer were adopted rapidly and widely during 2002–2005 without proof of their cost-effectiveness.

Tags: ProstateCancer

  • Dr. Philip Kantoff says the United States Preventive Services Task Force's conclusion that prostate-specific antigen (PSA) testing provides limited value is the wrong message.

Tags: ProstateCancer

  • Hormone-blocking therapy for prostate cancer doesn’t raise the risk of fatal heart attacks - as some recent studies had suggested - according to a new report from Dana-Farber/Brigham and Women’s Cancer Center.

Tags: Hormones, ProstateCancer

  • A new SU2C and Prostate Cancer Foundation Dream Team, dedicated to advanced prostate cancer research, includes two Dana-Farber researchers among scientists from leading prostate cancer centers in the U.S. and England.

Tags: ProstateCancer

  • Dana-Farber researchers have demonstrated that a hormone-depleting drug can help eliminate or nearly eliminate aggressive prostate cancers that have yet to spread beyond the prostate.

Tags: Hormones, ProstateCancer, TranslationalResearch

  • Dana-Farber scientists have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones, a finding that could serve as a treatment target for castration-resistant prostate cancers.

Tags: BasicResearch, ProstateCancer

  • Researchers at Dana-Farber/Brigham and Women's Cancer Center report a small percentage of men in a prostate cancer study complained that their penis seemed shorter following treatment, causing them to regret the type of treatment they chose.

Tags: ProstateCancer, PopulationScience

  • Dana-Farber researchers find many men with low-risk, localized prostate cancers can safely choose observation instead of undergoing immediate treatment and have a better quality of life while reducing health care costs.

Tags: ProstateCancer, PopulationScience

Showing 11-19 of 19 items